Redeye updates on Invisio following its Q4-results which came in much better than expected. The outlook for 2023 is strenghted as well and we have raised estimates and valuation range where our new base case stands at SEK230 (SEK190).
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/